ログイン

biopharmaceutics

biopharmaceutics
59問 • 1年前
  • Hannah Angelique Losaria
  • 通報

    問題一覧

  • 1

    the study of pharmacotechnical factors in the drug products that ccan affect the pharmacokinetics of drugs -study of dosage forms and its dissolution properties

    biopharmaceutics

  • 2

    study of the pocess that a drug undergoes from the moment it enters the body unti it leaves - what the body doesto the drug

    pharmacokinetics

  • 3

    THE ONLY BIOPHARMACEUTICS PROCESS -the process of converting the drug product to its solution form -a highly modifiable process and is considered as one of the primary determinants of the onset of action and duration of action

    liberation

  • 4

    rate and extent of drug entry into the sytemic circulation

    absorption

  • 5

    movement of drug from systemic circulation to different compartments

    distribution

  • 6

    process of converting drugs to a less active form

    metabolism

  • 7

    a space in the body pertaining to organs and tissues deemed as kinetically homogenous

    compartments

  • 8

    *a measure of how much the concentration changes from one compartment to another

    concentration gradient

  • 9

    the process of removing or introducing a substance to a compartment

    transport

  • 10

    ionized

    charged

  • 11

    unionized

    uncharged

  • 12

    dominates when a substance is introduced to an environment with OPPOSITE ph

    ionized

  • 13

    dominates when a substance isintrodced to an environment with the SAME ph

    unionized

  • 14

    dissolution is governed by what equation

    noyes-whitney

  • 15

    intrasynovial

    joint fluid area

  • 16

    intraarticular

    joint space

  • 17

    intrathecal

    cerebrospinal

  • 18

    lowest possible concentration to cause an effect

    minimum effective concentration

  • 19

    minimum toxic concentration is the highest concentration possible to cause an effect without any toxic effects

    maximum therapeutic concentration

  • 20

    -high doseing frequency------ risk of noncompliace especially if polypharmacy -has the least lag time/liberation -fast onset, short duration

    immediate release

  • 21

    -follows immediate release graph but allows for a second release -fast onset

    bimodal release

  • 22

    -lag time is longer than that of the immediate release graph but allows for a second release graph -slow onset, short duration

    delayed release

  • 23

    -used to lower frequency of dosing -fast onset, long duration

    extnded release

  • 24

    ratio of solubility in oil and water

    partition coefficient

  • 25

    high partition coefficient

    lipid soluble

  • 26

    low partition coefficient

    water soluble

  • 27

    ionized-water soluble

    dissolution

  • 28

    unionized-lipid soluble

    absorption

  • 29

    amorphous form is more easily soluble than its crystallne form

    polymrphism

  • 30

    recemic- equal portions of levo and dextro isomers

    chirality

  • 31

    -makes nonpolar drugs soluble in polar solvents

    slt formation

  • 32

    compounnds containing water, making it easier to dissolve

    hydrates

  • 33

    creates a bigger compoud, making it less soluble

    complex formation

  • 34

    who proposed the theory of cell membranes

    davson and danieli

  • 35

    two layers of phospholipids wiith the hydrophilic heads faciing outside and the hydrophobic tails inside

    unit membrane theory/lipid bilayer

  • 36

    the lipid bilayer has proteins embedded in the matrix

    fluid mosaic model

  • 37

    proteins embedded in the matrix are used as receptors and for transport

    modified fuid mosaic

  • 38

    -most common but slowest -moves along the concentration gradient an therefore does not need ATP -does not need any carrier -based on fick's law of diffusion

    passive diffusion

  • 39

    -rate of diffusion is directly proportional to partition coefficient, surface area, concentration gradient -rate of diffusion is inversely proportional to the thickness of the membrane

    fick's law

  • 40

    -stereo specific -competetive and saturable -follow michaeli menten kinetics

    carrier-mediated transport

  • 41

    direction of facilitated diffusion

    alonng the concentration gradient

  • 42

    direction of active transport

    against the concentration gradient

  • 43

    -via water filled pores or channels -along the concentration gradient -solvent drag- ions move along the same direction as water -opposite charges -MW: 150-400 -transport system used by electrolytes

    convective transport

  • 44

    drug ions bind to endogenous ions to form a neutral complex which is uncharged and is capable of passive diffusion

    ion pair transport

  • 45

    -envagenation of cell membrane *phagocytosis *endocytosis *pinocytosis *exocytosis

    vesicular transport

  • 46

    the measure of rate and extent of drug entry into the sytemic circulation

    bioavailability

  • 47

    maximum plasma concentration -most variable parameter -measures rate and extent

    cmax

  • 48

    time it takes to reach cmax -measures rate

    tmax

  • 49

    area under the curve -measures extent

    auc

  • 50

    the ratio of generic to innovator in terms of the pharmacokinetic parameters of biovailability

    bioequivalence

  • 51

    same in all aspects but may differ in excipients

    pharmaceutical equivalent

  • 52

    same API, different dose or dosage form

    pharmaceutical alternative

  • 53

    same safety and efficacy- bioequivlent and phharmaceutical equivalent

    therapeutic equivalent

  • 54

    different api, same drug class

    therapeutic alternative

  • 55

    classification of drugs based on dissolution and intestinal permeability, which affects absorption of the API

    biopharmaceutics classification system

  • 56

    cardiac output regional blood flow

    physiological factors

  • 57

    for acidic drugs

    albumin

  • 58

    for hormones

    globulin

  • 59

    allows exchange of nutrients between the mother and the fetus

    placetal barrier

  • gastro

    gastro

    Hannah Angelique Losaria · 100問 · 2年前

    gastro

    gastro

    100問 • 2年前
    Hannah Angelique Losaria

    gastro m

    gastro m

    Hannah Angelique Losaria · 7問 · 2年前

    gastro m

    gastro m

    7問 • 2年前
    Hannah Angelique Losaria

    lab

    lab

    Hannah Angelique Losaria · 13問 · 2年前

    lab

    lab

    13問 • 2年前
    Hannah Angelique Losaria

    m2

    m2

    Hannah Angelique Losaria · 94問 · 2年前

    m2

    m2

    94問 • 2年前
    Hannah Angelique Losaria

    m1

    m1

    Hannah Angelique Losaria · 88問 · 2年前

    m1

    m1

    88問 • 2年前
    Hannah Angelique Losaria

    poisons

    poisons

    Hannah Angelique Losaria · 50問 · 2年前

    poisons

    poisons

    50問 • 2年前
    Hannah Angelique Losaria

    lec

    lec

    Hannah Angelique Losaria · 19問 · 2年前

    lec

    lec

    19問 • 2年前
    Hannah Angelique Losaria

    exam

    exam

    Hannah Angelique Losaria · 16問 · 2年前

    exam

    exam

    16問 • 2年前
    Hannah Angelique Losaria

    spec

    spec

    Hannah Angelique Losaria · 41問 · 2年前

    spec

    spec

    41問 • 2年前
    Hannah Angelique Losaria

    midterm

    midterm

    Hannah Angelique Losaria · 55問 · 1年前

    midterm

    midterm

    55問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    Hannah Angelique Losaria · 54問 · 1年前

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    54問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    Hannah Angelique Losaria · 29問 · 1年前

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    29問 • 1年前
    Hannah Angelique Losaria

    DDS

    DDS

    Hannah Angelique Losaria · 33問 · 1年前

    DDS

    DDS

    33問 • 1年前
    Hannah Angelique Losaria

    hallucinogens

    hallucinogens

    Hannah Angelique Losaria · 22問 · 1年前

    hallucinogens

    hallucinogens

    22問 • 1年前
    Hannah Angelique Losaria

    non volatile poisons

    non volatile poisons

    Hannah Angelique Losaria · 42問 · 1年前

    non volatile poisons

    non volatile poisons

    42問 • 1年前
    Hannah Angelique Losaria

    endterm

    endterm

    Hannah Angelique Losaria · 63問 · 1年前

    endterm

    endterm

    63問 • 1年前
    Hannah Angelique Losaria

    q3 endterm

    q3 endterm

    Hannah Angelique Losaria · 17問 · 1年前

    q3 endterm

    q3 endterm

    17問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019

    mockboard 2019

    Hannah Angelique Losaria · 65問 · 1年前

    mockboard 2019

    mockboard 2019

    65問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019 II

    mockboard 2019 II

    Hannah Angelique Losaria · 39問 · 1年前

    mockboard 2019 II

    mockboard 2019 II

    39問 • 1年前
    Hannah Angelique Losaria

    miss mel reviewer

    miss mel reviewer

    Hannah Angelique Losaria · 36問 · 1年前

    miss mel reviewer

    miss mel reviewer

    36問 • 1年前
    Hannah Angelique Losaria

    miss roma high yield

    miss roma high yield

    Hannah Angelique Losaria · 9問 · 1年前

    miss roma high yield

    miss roma high yield

    9問 • 1年前
    Hannah Angelique Losaria

    micro highlights

    micro highlights

    Hannah Angelique Losaria · 12問 · 1年前

    micro highlights

    micro highlights

    12問 • 1年前
    Hannah Angelique Losaria

    module 6 AUgdguwegfiuwegfu

    module 6 AUgdguwegfiuwegfu

    Hannah Angelique Losaria · 24問 · 1年前

    module 6 AUgdguwegfiuwegfu

    module 6 AUgdguwegfiuwegfu

    24問 • 1年前
    Hannah Angelique Losaria

    mod6 sure

    mod6 sure

    Hannah Angelique Losaria · 75問 · 1年前

    mod6 sure

    mod6 sure

    75問 • 1年前
    Hannah Angelique Losaria

    manufacturing

    manufacturing

    Hannah Angelique Losaria · 100問 · 1年前

    manufacturing

    manufacturing

    100問 • 1年前
    Hannah Angelique Losaria

    module 5

    module 5

    Hannah Angelique Losaria · 94問 · 1年前

    module 5

    module 5

    94問 • 1年前
    Hannah Angelique Losaria

    mod5

    mod5

    Hannah Angelique Losaria · 98問 · 1年前

    mod5

    mod5

    98問 • 1年前
    Hannah Angelique Losaria

    5555555555

    5555555555

    Hannah Angelique Losaria · 100問 · 1年前

    5555555555

    5555555555

    100問 • 1年前
    Hannah Angelique Losaria

    brex

    brex

    Hannah Angelique Losaria · 100問 · 1年前

    brex

    brex

    100問 • 1年前
    Hannah Angelique Losaria

    mod4

    mod4

    Hannah Angelique Losaria · 44問 · 1年前

    mod4

    mod4

    44問 • 1年前
    Hannah Angelique Losaria

    tox lab

    tox lab

    Hannah Angelique Losaria · 69問 · 1年前

    tox lab

    tox lab

    69問 • 1年前
    Hannah Angelique Losaria

    toxicology

    toxicology

    Hannah Angelique Losaria · 86問 · 1年前

    toxicology

    toxicology

    86問 • 1年前
    Hannah Angelique Losaria

    non volatile

    non volatile

    Hannah Angelique Losaria · 49問 · 1年前

    non volatile

    non volatile

    49問 • 1年前
    Hannah Angelique Losaria

    gosel and bricker

    gosel and bricker

    Hannah Angelique Losaria · 15問 · 1年前

    gosel and bricker

    gosel and bricker

    15問 • 1年前
    Hannah Angelique Losaria

    management of ADRs bariles

    management of ADRs bariles

    Hannah Angelique Losaria · 19問 · 1年前

    management of ADRs bariles

    management of ADRs bariles

    19問 • 1年前
    Hannah Angelique Losaria

    quiz 4

    quiz 4

    Hannah Angelique Losaria · 16問 · 1年前

    quiz 4

    quiz 4

    16問 • 1年前
    Hannah Angelique Losaria

    pcol miss gift exam

    pcol miss gift exam

    Hannah Angelique Losaria · 63問 · 1年前

    pcol miss gift exam

    pcol miss gift exam

    63問 • 1年前
    Hannah Angelique Losaria

    expirement 2- antidotes

    expirement 2- antidotes

    Hannah Angelique Losaria · 27問 · 1年前

    expirement 2- antidotes

    expirement 2- antidotes

    27問 • 1年前
    Hannah Angelique Losaria

    volatile poisons

    volatile poisons

    Hannah Angelique Losaria · 28問 · 1年前

    volatile poisons

    volatile poisons

    28問 • 1年前
    Hannah Angelique Losaria

    Drugs acting on the central nercous sytem

    Drugs acting on the central nercous sytem

    Hannah Angelique Losaria · 37問 · 1年前

    Drugs acting on the central nercous sytem

    Drugs acting on the central nercous sytem

    37問 • 1年前
    Hannah Angelique Losaria

    anti arrhythmic drugs

    anti arrhythmic drugs

    Hannah Angelique Losaria · 20問 · 1年前

    anti arrhythmic drugs

    anti arrhythmic drugs

    20問 • 1年前
    Hannah Angelique Losaria

    antiplatelet drugs

    antiplatelet drugs

    Hannah Angelique Losaria · 17問 · 1年前

    antiplatelet drugs

    antiplatelet drugs

    17問 • 1年前
    Hannah Angelique Losaria

    Cardiovascular Drugs

    Cardiovascular Drugs

    Hannah Angelique Losaria · 31問 · 1年前

    Cardiovascular Drugs

    Cardiovascular Drugs

    31問 • 1年前
    Hannah Angelique Losaria

    barbiturates

    barbiturates

    Hannah Angelique Losaria · 26問 · 1年前

    barbiturates

    barbiturates

    26問 • 1年前
    Hannah Angelique Losaria

    physical pharmacy

    physical pharmacy

    Hannah Angelique Losaria · 34問 · 1年前

    physical pharmacy

    physical pharmacy

    34問 • 1年前
    Hannah Angelique Losaria

    plasma

    plasma

    Hannah Angelique Losaria · 10問 · 1年前

    plasma

    plasma

    10問 • 1年前
    Hannah Angelique Losaria

    endterm

    endterm

    Hannah Angelique Losaria · 73問 · 1年前

    endterm

    endterm

    73問 • 1年前
    Hannah Angelique Losaria

    juris

    juris

    Hannah Angelique Losaria · 55問 · 1年前

    juris

    juris

    55問 • 1年前
    Hannah Angelique Losaria

    dds

    dds

    Hannah Angelique Losaria · 100問 · 1年前

    dds

    dds

    100問 • 1年前
    Hannah Angelique Losaria

    55

    55

    Hannah Angelique Losaria · 92問 · 1年前

    55

    55

    92問 • 1年前
    Hannah Angelique Losaria

    dddssss

    dddssss

    Hannah Angelique Losaria · 19問 · 1年前

    dddssss

    dddssss

    19問 • 1年前
    Hannah Angelique Losaria

    manuf

    manuf

    Hannah Angelique Losaria · 59問 · 1年前

    manuf

    manuf

    59問 • 1年前
    Hannah Angelique Losaria

    qc/qa

    qc/qa

    Hannah Angelique Losaria · 67問 · 1年前

    qc/qa

    qc/qa

    67問 • 1年前
    Hannah Angelique Losaria

    qc qa identification

    qc qa identification

    Hannah Angelique Losaria · 83問 · 1年前

    qc qa identification

    qc qa identification

    83問 • 1年前
    Hannah Angelique Losaria

    quali/ quanti ppt

    quali/ quanti ppt

    Hannah Angelique Losaria · 100問 · 1年前

    quali/ quanti ppt

    quali/ quanti ppt

    100問 • 1年前
    Hannah Angelique Losaria

    quali/quanti 2

    quali/quanti 2

    Hannah Angelique Losaria · 23問 · 1年前

    quali/quanti 2

    quali/quanti 2

    23問 • 1年前
    Hannah Angelique Losaria

    quali quanti identification

    quali quanti identification

    Hannah Angelique Losaria · 68問 · 1年前

    quali quanti identification

    quali quanti identification

    68問 • 1年前
    Hannah Angelique Losaria

    microbiology: introduction and bacterial anatomy

    microbiology: introduction and bacterial anatomy

    Hannah Angelique Losaria · 37問 · 1年前

    microbiology: introduction and bacterial anatomy

    microbiology: introduction and bacterial anatomy

    37問 • 1年前
    Hannah Angelique Losaria

    mocrobiology: bacterial stain, nutrition, bacterial recombination, growth phrases, microbial growth factor, culture media

    mocrobiology: bacterial stain, nutrition, bacterial recombination, growth phrases, microbial growth factor, culture media

    Hannah Angelique Losaria · 60問 · 1年前

    mocrobiology: bacterial stain, nutrition, bacterial recombination, growth phrases, microbial growth factor, culture media

    mocrobiology: bacterial stain, nutrition, bacterial recombination, growth phrases, microbial growth factor, culture media

    60問 • 1年前
    Hannah Angelique Losaria

    microbiology: bacteriology part 1

    microbiology: bacteriology part 1

    Hannah Angelique Losaria · 28問 · 1年前

    microbiology: bacteriology part 1

    microbiology: bacteriology part 1

    28問 • 1年前
    Hannah Angelique Losaria

    microbiology: bacteriology part 2

    microbiology: bacteriology part 2

    Hannah Angelique Losaria · 48問 · 1年前

    microbiology: bacteriology part 2

    microbiology: bacteriology part 2

    48問 • 1年前
    Hannah Angelique Losaria

    microbiology: mycology

    microbiology: mycology

    Hannah Angelique Losaria · 20問 · 1年前

    microbiology: mycology

    microbiology: mycology

    20問 • 1年前
    Hannah Angelique Losaria

    microbio identification 1

    microbio identification 1

    Hannah Angelique Losaria · 48問 · 1年前

    microbio identification 1

    microbio identification 1

    48問 • 1年前
    Hannah Angelique Losaria

    miss gift

    miss gift

    Hannah Angelique Losaria · 38問 · 1年前

    miss gift

    miss gift

    38問 • 1年前
    Hannah Angelique Losaria

    microbiology 2

    microbiology 2

    Hannah Angelique Losaria · 21問 · 1年前

    microbiology 2

    microbiology 2

    21問 • 1年前
    Hannah Angelique Losaria

    microbio 3

    microbio 3

    Hannah Angelique Losaria · 18問 · 1年前

    microbio 3

    microbio 3

    18問 • 1年前
    Hannah Angelique Losaria

    microbio 4

    microbio 4

    Hannah Angelique Losaria · 10問 · 1年前

    microbio 4

    microbio 4

    10問 • 1年前
    Hannah Angelique Losaria

    microbio anatomy

    microbio anatomy

    Hannah Angelique Losaria · 30問 · 1年前

    microbio anatomy

    microbio anatomy

    30問 • 1年前
    Hannah Angelique Losaria

    Drugs acting on the central nercous sytem

    Drugs acting on the central nercous sytem

    Hannah Angelique Losaria · 37問 · 1年前

    Drugs acting on the central nercous sytem

    Drugs acting on the central nercous sytem

    37問 • 1年前
    Hannah Angelique Losaria

    microbio5

    microbio5

    Hannah Angelique Losaria · 17問 · 1年前

    microbio5

    microbio5

    17問 • 1年前
    Hannah Angelique Losaria

    microbio6

    microbio6

    Hannah Angelique Losaria · 13問 · 1年前

    microbio6

    microbio6

    13問 • 1年前
    Hannah Angelique Losaria

    pub health 1

    pub health 1

    Hannah Angelique Losaria · 34問 · 1年前

    pub health 1

    pub health 1

    34問 • 1年前
    Hannah Angelique Losaria

    microbio7

    microbio7

    Hannah Angelique Losaria · 30問 · 1年前

    microbio7

    microbio7

    30問 • 1年前
    Hannah Angelique Losaria

    public health

    public health

    Hannah Angelique Losaria · 31問 · 1年前

    public health

    public health

    31問 • 1年前
    Hannah Angelique Losaria

    pacop

    pacop

    Hannah Angelique Losaria · 40問 · 1年前

    pacop

    pacop

    40問 • 1年前
    Hannah Angelique Losaria

    inorganic pharmaceutical pharmacy

    inorganic pharmaceutical pharmacy

    Hannah Angelique Losaria · 98問 · 1年前

    inorganic pharmaceutical pharmacy

    inorganic pharmaceutical pharmacy

    98問 • 1年前
    Hannah Angelique Losaria

    transition metal iron triad FE CO NI

    transition metal iron triad FE CO NI

    Hannah Angelique Losaria · 10問 · 1年前

    transition metal iron triad FE CO NI

    transition metal iron triad FE CO NI

    10問 • 1年前
    Hannah Angelique Losaria

    licensing

    licensing

    Hannah Angelique Losaria · 8問 · 1年前

    licensing

    licensing

    8問 • 1年前
    Hannah Angelique Losaria

    most common side effects

    most common side effects

    Hannah Angelique Losaria · 26問 · 1年前

    most common side effects

    most common side effects

    26問 • 1年前
    Hannah Angelique Losaria

    chemistry people

    chemistry people

    Hannah Angelique Losaria · 10問 · 1年前

    chemistry people

    chemistry people

    10問 • 1年前
    Hannah Angelique Losaria

    pharmacognosy people

    pharmacognosy people

    Hannah Angelique Losaria · 10問 · 1年前

    pharmacognosy people

    pharmacognosy people

    10問 • 1年前
    Hannah Angelique Losaria

    drug of choice

    drug of choice

    Hannah Angelique Losaria · 29問 · 1年前

    drug of choice

    drug of choice

    29問 • 1年前
    Hannah Angelique Losaria

    common antidotes

    common antidotes

    Hannah Angelique Losaria · 19問 · 1年前

    common antidotes

    common antidotes

    19問 • 1年前
    Hannah Angelique Losaria

    vitamin functions and deficiencies

    vitamin functions and deficiencies

    Hannah Angelique Losaria · 25問 · 1年前

    vitamin functions and deficiencies

    vitamin functions and deficiencies

    25問 • 1年前
    Hannah Angelique Losaria

    inorganic pharmaceutical pharmacy 2

    inorganic pharmaceutical pharmacy 2

    Hannah Angelique Losaria · 97問 · 1年前

    inorganic pharmaceutical pharmacy 2

    inorganic pharmaceutical pharmacy 2

    97問 • 1年前
    Hannah Angelique Losaria

    1

    1

    Hannah Angelique Losaria · 100問 · 1年前

    1

    1

    100問 • 1年前
    Hannah Angelique Losaria

    2

    2

    Hannah Angelique Losaria · 42問 · 1年前

    2

    2

    42問 • 1年前
    Hannah Angelique Losaria

    1

    1

    Hannah Angelique Losaria · 62問 · 1年前

    1

    1

    62問 • 1年前
    Hannah Angelique Losaria

    inorganic pharm chem 3

    inorganic pharm chem 3

    Hannah Angelique Losaria · 48問 · 1年前

    inorganic pharm chem 3

    inorganic pharm chem 3

    48問 • 1年前
    Hannah Angelique Losaria

    2

    2

    Hannah Angelique Losaria · 66問 · 1年前

    2

    2

    66問 • 1年前
    Hannah Angelique Losaria

    3

    3

    Hannah Angelique Losaria · 60問 · 1年前

    3

    3

    60問 • 1年前
    Hannah Angelique Losaria

    4

    4

    Hannah Angelique Losaria · 43問 · 1年前

    4

    4

    43問 • 1年前
    Hannah Angelique Losaria

    1

    1

    Hannah Angelique Losaria · 100問 · 1年前

    1

    1

    100問 • 1年前
    Hannah Angelique Losaria

    2

    2

    Hannah Angelique Losaria · 100問 · 1年前

    2

    2

    100問 • 1年前
    Hannah Angelique Losaria

    3

    3

    Hannah Angelique Losaria · 79問 · 1年前

    3

    3

    79問 • 1年前
    Hannah Angelique Losaria

    問題一覧

  • 1

    the study of pharmacotechnical factors in the drug products that ccan affect the pharmacokinetics of drugs -study of dosage forms and its dissolution properties

    biopharmaceutics

  • 2

    study of the pocess that a drug undergoes from the moment it enters the body unti it leaves - what the body doesto the drug

    pharmacokinetics

  • 3

    THE ONLY BIOPHARMACEUTICS PROCESS -the process of converting the drug product to its solution form -a highly modifiable process and is considered as one of the primary determinants of the onset of action and duration of action

    liberation

  • 4

    rate and extent of drug entry into the sytemic circulation

    absorption

  • 5

    movement of drug from systemic circulation to different compartments

    distribution

  • 6

    process of converting drugs to a less active form

    metabolism

  • 7

    a space in the body pertaining to organs and tissues deemed as kinetically homogenous

    compartments

  • 8

    *a measure of how much the concentration changes from one compartment to another

    concentration gradient

  • 9

    the process of removing or introducing a substance to a compartment

    transport

  • 10

    ionized

    charged

  • 11

    unionized

    uncharged

  • 12

    dominates when a substance is introduced to an environment with OPPOSITE ph

    ionized

  • 13

    dominates when a substance isintrodced to an environment with the SAME ph

    unionized

  • 14

    dissolution is governed by what equation

    noyes-whitney

  • 15

    intrasynovial

    joint fluid area

  • 16

    intraarticular

    joint space

  • 17

    intrathecal

    cerebrospinal

  • 18

    lowest possible concentration to cause an effect

    minimum effective concentration

  • 19

    minimum toxic concentration is the highest concentration possible to cause an effect without any toxic effects

    maximum therapeutic concentration

  • 20

    -high doseing frequency------ risk of noncompliace especially if polypharmacy -has the least lag time/liberation -fast onset, short duration

    immediate release

  • 21

    -follows immediate release graph but allows for a second release -fast onset

    bimodal release

  • 22

    -lag time is longer than that of the immediate release graph but allows for a second release graph -slow onset, short duration

    delayed release

  • 23

    -used to lower frequency of dosing -fast onset, long duration

    extnded release

  • 24

    ratio of solubility in oil and water

    partition coefficient

  • 25

    high partition coefficient

    lipid soluble

  • 26

    low partition coefficient

    water soluble

  • 27

    ionized-water soluble

    dissolution

  • 28

    unionized-lipid soluble

    absorption

  • 29

    amorphous form is more easily soluble than its crystallne form

    polymrphism

  • 30

    recemic- equal portions of levo and dextro isomers

    chirality

  • 31

    -makes nonpolar drugs soluble in polar solvents

    slt formation

  • 32

    compounnds containing water, making it easier to dissolve

    hydrates

  • 33

    creates a bigger compoud, making it less soluble

    complex formation

  • 34

    who proposed the theory of cell membranes

    davson and danieli

  • 35

    two layers of phospholipids wiith the hydrophilic heads faciing outside and the hydrophobic tails inside

    unit membrane theory/lipid bilayer

  • 36

    the lipid bilayer has proteins embedded in the matrix

    fluid mosaic model

  • 37

    proteins embedded in the matrix are used as receptors and for transport

    modified fuid mosaic

  • 38

    -most common but slowest -moves along the concentration gradient an therefore does not need ATP -does not need any carrier -based on fick's law of diffusion

    passive diffusion

  • 39

    -rate of diffusion is directly proportional to partition coefficient, surface area, concentration gradient -rate of diffusion is inversely proportional to the thickness of the membrane

    fick's law

  • 40

    -stereo specific -competetive and saturable -follow michaeli menten kinetics

    carrier-mediated transport

  • 41

    direction of facilitated diffusion

    alonng the concentration gradient

  • 42

    direction of active transport

    against the concentration gradient

  • 43

    -via water filled pores or channels -along the concentration gradient -solvent drag- ions move along the same direction as water -opposite charges -MW: 150-400 -transport system used by electrolytes

    convective transport

  • 44

    drug ions bind to endogenous ions to form a neutral complex which is uncharged and is capable of passive diffusion

    ion pair transport

  • 45

    -envagenation of cell membrane *phagocytosis *endocytosis *pinocytosis *exocytosis

    vesicular transport

  • 46

    the measure of rate and extent of drug entry into the sytemic circulation

    bioavailability

  • 47

    maximum plasma concentration -most variable parameter -measures rate and extent

    cmax

  • 48

    time it takes to reach cmax -measures rate

    tmax

  • 49

    area under the curve -measures extent

    auc

  • 50

    the ratio of generic to innovator in terms of the pharmacokinetic parameters of biovailability

    bioequivalence

  • 51

    same in all aspects but may differ in excipients

    pharmaceutical equivalent

  • 52

    same API, different dose or dosage form

    pharmaceutical alternative

  • 53

    same safety and efficacy- bioequivlent and phharmaceutical equivalent

    therapeutic equivalent

  • 54

    different api, same drug class

    therapeutic alternative

  • 55

    classification of drugs based on dissolution and intestinal permeability, which affects absorption of the API

    biopharmaceutics classification system

  • 56

    cardiac output regional blood flow

    physiological factors

  • 57

    for acidic drugs

    albumin

  • 58

    for hormones

    globulin

  • 59

    allows exchange of nutrients between the mother and the fetus

    placetal barrier